Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/1069548

Download in:

View as

General Info

PMID
1069548